Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy

We examined binding to excitatory amino acid and inhibitory amino acid receptors in frozen hippocampal sections prepared from surgical specimens resected from 8 individuals with medically refractory temporal lobe epilepsy. The excitatory receptors studied included N‐methyl‐D‐aspartate (NMDA), strychnine‐insensitive glycine, phencyclidine, and quisqualate. The inhibitory receptors studied were gamma‐aminobutyric acid type A (GABAA) and benzodiazepine. Excitatory and inhibitory amino acid receptor binding were differentially altered in the patients with temporal lobe epilepsy in comparison to 8 age‐comparable autopsy control subjects, and changes in receptor binding were regionally selective in four areas. Binding to phencyclidine receptors associated with the NMDA channel was reduced by 35 to 70% in all regions in the hippocampi of the patients. In contrast, binding to the NMDA recognition site and its associated glycine modulatory site was elevated by 20 to 110% in the cornu ammonis (CA) 1 area and dentate gyrus of the hippocampus of the patients. Binding to these sites was unaffected in area CA4. Binding to the quisqualate‐type excitatory amino acid receptor was unchanged in all regions except the stratum lacunosum moleculare CA1, where it was increased by 63%. GABAA and benzodiazepine receptor binding was reduced by 20 to 60% in CA1 and CA4, but unchanged in dentate gyrus. The data indicate that excitatory and inhibitory amino acid receptors are altered in the hippocampus of patients with temporal lobe epilepsy.

[1]  K A Frey,et al.  Changes in [3H]muscimol binding in substantia nigra, entopeduncular nucleus, globus pallidus, and thalamus after striatal lesions as demonstrated by quantitative receptor autoradiography , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[2]  E. Roberts.  Epilepsy and antiepileptic drugs: a speculative synthesis. , 1980, Advances in neurology.

[3]  A. Sherwin,et al.  Benzodiazepine receptor binding is not altered in human epileptogenic cortical foci , 1986, Neurology.

[4]  B. Engelsen.  Neurotransmitter glutamate: its clinical importance , 1986, Acta neurologica Scandinavica.

[5]  W. J. Brown,et al.  Temporal Lobe Volumetric Cell Densities in Temporal Lobe Epilepsy , 1984, Epilepsia.

[6]  S. Govoni,et al.  Calcium Entry Blockers and Tissue Protection , 1984 .

[7]  R. Dingledine.  NMDA Receptors: what do they do? , 1986, Trends in Neurosciences.

[8]  B. Meldrum,et al.  Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid. , 1982, European journal of pharmacology.

[9]  D. Clifford,et al.  Ketamine and MK-801 prevent degeneration of thalamic neurons induced by focal cortical seizures , 1989, Experimental Neurology.

[10]  A. M. Dam.  Hippocampal neuron loss in epilepsy and after experimental seizures , 1982 .

[11]  J. Olney.  Excitatory transmitters and epilepsy-related brain damage. , 1985, International review of neurobiology.

[12]  C. Cotman,et al.  Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease , 1986, Brain Research.

[13]  R. Olsen.  GABA‐Benzodiazepine‐Barbiturate Receptor Interactions , 1981, Journal of neurochemistry.

[14]  J. Hablitz,et al.  N-methyl-D-aspartate receptor antagonists reduce synaptic excitation in the hippocampus , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  J. Penney,et al.  Characterization and regional distribution of strychnine-insensitive [3H]glycine binding sites in rat brain by quantitative receptor autoradiography , 1990, Neuroscience.

[16]  J. Penney,et al.  Loss of hippocampal [3H]TCP binding in Alzheimer's disease , 1987, Neuroscience Letters.

[17]  C. Cotman,et al.  Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells , 1978, Nature.

[18]  R. S. Sloviter,et al.  “Epileptic” brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine , 1985, Brain Research Bulletin.

[19]  D. Biddle,et al.  Conservative management of focal intracerebral infection , 1981, Neurology.

[20]  T. Rasmussen,et al.  Amino acid content of epileptogenic human brain: focal versus surrounding regions. , 1972, Brain research.

[21]  M. Avoli,et al.  Bursting in human epileptogenic neocortex is depressed by an N-methyl-d-aspartate antagonist , 1987, Neuroscience Letters.

[22]  J. H. Kim,et al.  Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy , 1989, Brain Research.

[23]  G. Collingridge,et al.  Intracellular demonstration of an N-methyl-d-aspartate receptor mediated component of synaptic transmission in the rat hippocampus , 1985, Neuroscience Letters.

[24]  J. Penney,et al.  Dementia of the Alzheimer's Type: Changes in Hippocampal L‐[3H]Glutamate Binding , 1987, Journal of neurochemistry.

[25]  M. Gilbert.  The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures , 1988, Brain Research.

[26]  J. Penney,et al.  Quantitative autoradiography of neurotransmitter receptors in Huntington disease , 1982, Neurology.

[27]  A. Procter,et al.  Reduced Glycine Stimulation of [3H]MK‐801 Binding in Alzheimer's Disease , 1989, Journal of neurochemistry.

[28]  M. Mattson.  Neurotransmitters in the regulation of neuronal cytoarchitecture , 1988, Brain Research Reviews.

[29]  B. Meldrum,et al.  Anticonvulsant action of excitatory amino acid antagonists. , 1982, Science.

[30]  J. Cramer,et al.  Tremor due to sodium valproate , 1981, Neurology.

[31]  D. Mcintyre,et al.  Pyriform cortex involvement in kindling , 1989, Neuroscience & Biobehavioral Reviews.

[32]  R. S. Sloviter.  On the role of seizure activity and endogenous excitatory amino acids in mediating seizure-associated hippocampal damage. , 1986, Advances in experimental medicine and biology.

[33]  L. Iversen,et al.  Excitatory amino acids in the brain - focus on NMDA receptors , 1987, Trends in Neurosciences.

[34]  C. Cotman,et al.  N-methyl-d-aspartate receptors in the cortex and hippocampus of baboon (Papio anubis andPapio papio) , 1989, Neuroscience.

[35]  J. McNamara,et al.  N-methyl-D-aspartate receptor plasticity in kindling: quantitative and qualitative alterations in the N-methyl-D-aspartate receptor-channel complex. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  A. Cross,et al.  Loss of glycine-dependent radioligand binding to the N-methyl-d-aspartate-phencyclidine receptor complex in patients with Alzheimer's disease , 1989, Neuroscience Letters.

[37]  B. Meldrum.  Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. , 1985, Clinical science.

[38]  J. Penney,et al.  Anatomic correlation of NMDA and 3H-TCP-labeled receptors in rat brain , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  A. Scheibel,et al.  The Hippocampal‐Dentate Complex in Temporal Lobe Epilepsy , 1974, Epilepsia.

[40]  J. Cavazos,et al.  Synaptic reorganization in the hippocampus induced by abnormal functional activity. , 1988, Science.

[41]  A. Mouritze Dam.  Hippocampal neuron loss in epilepsy and after experimental seizures. , 1982, Acta neurologica Scandinavica.

[42]  Keiko Sato,et al.  Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy , 1988, Brain Research.

[43]  R. S. Sloviter,et al.  “Epileptic” brain damage in rats induced by sustained electrical stimulation of the perforant path. II. Ultrastructural analysis of acute hippocampal pathology , 1983, Brain Research Bulletin.

[44]  M. Johnston,et al.  MK-801 pretreatment enhances N-methyl-d-aspartate-mediated brain injury and increases brain N-methyl-d-aspartate recognition site binding in rats , 1990, Neuroscience.

[45]  E. Wong,et al.  Non-competitive antagonists of excitatory amino acid receptors , 1987, Trends in Neurosciences.

[46]  E. Roberts.  GABA‐Related phenomena, models of nervous system function, and seizures , 1984, Annals of neurology.

[47]  J. Gotman,et al.  Excitatory amino acids are elevated in human epileptic cerebral cortex , 1988, Neurology.

[48]  R. S. Sloviter.  “Epileptic” brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies , 1983, Brain Research Bulletin.

[49]  D. Tauck,et al.  Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  A. Palmer,et al.  The N-methyl-d-aspartate receptor complex in Alzheimer's disease: reduced regulation by glycine but not zinc , 1989, Brain Research.

[51]  J. Penney,et al.  Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate- and kainate-sensitive glutamate binding sites. , 1985, The Journal of pharmacology and experimental therapeutics.

[52]  The GABA postsynaptic membrane receptor-ionophore complex , 1981 .

[53]  J. Olney,et al.  Acute dendrotoxic changes in the hippocampus of kainate treated rats , 1979, Brain Research.

[54]  W. Burnham.  The GABA hypothesis of kindling: Recent assay studies , 1989, Neuroscience & Biobehavioral Reviews.

[55]  J. Penney,et al.  Benzodiazepine and GABA receptors in early Huntington's disease , 1984, Neurology.

[56]  R. D. Russell,et al.  Anticonvulsant and antiepileptogenic actions of MK-801 in the kindling and electroshock models , 1988, Neuropharmacology.

[57]  W. Haefely.  GABA and the anticonvulsant action of benzodiazepines and barbiturates , 1980, Brain Research Bulletin.

[58]  J. Bowyer.  Phencyclidine inhibition of the rate of development of amygdaloid kindled seizures , 1982, Experimental Neurology.

[59]  Kenneth M. Johnson,et al.  Linkage between phencyclidine (PCP) and N-methyl-d-aspartate (NMDA) receptors in the cerebellum , 1988, Brain Research.

[60]  Carl W. Cotman,et al.  Selective reinnervation of hippocampal area CA1 and the fascia dentata after destruction of CA3-CA4 afferents with kainic acid , 1980, Brain Research.

[61]  Michel Boisson,et al.  Abnormal neuronal discharges , 1978 .

[62]  Carl W. Cotman,et al.  Anatomical organization of excitatory amino acid receptors and their pathways , 1987, Trends in Neurosciences.

[63]  E. Serafetinides,et al.  ETIOLOGY AND PATHOGENESIS OF TEMPORAL LOBE EPILEPSY. , 1964, Archives of neurology.

[64]  Kenneth M. Johnson,et al.  Glycine potentiates N-methyl-d-aspartate-induced [3H]TCP binding to rat cortical membranes , 1987, Neuroscience Letters.

[65]  C. Cotman,et al.  Altered distribution of excitatory amino acid receptors in temporal lobe epilepsy , 1990, Experimental Neurology.

[66]  M. Williams,et al.  Radioligand binding to central phencyclidine recognition sites is dependent on excitatory amino acid receptor agonists. , 1986, European journal of pharmacology.

[67]  J H Margerison,et al.  Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. , 1966, Brain : a journal of neurology.

[68]  G. Collingridge,et al.  A selective N-methyl-d-aspartate antagonist depresses epileptiform activity in rat hippocampal slices , 1985, Neuroscience Letters.

[69]  D. Callaghan,et al.  Pharmacological modification of amygdaloid-kindled seizures , 1980, Neuropharmacology.

[70]  H. Shinozaki.  Pharmacology of the glutamate receptor , 1988, Progress in Neurobiology.

[71]  J. Penney,et al.  NMDA receptor losses in putamen from patients with Huntington's disease. , 1988, Science.

[72]  A. Snowman,et al.  Role of the γ‐Aminobytyric acid receptor—Ionophore complex in seizure disorders , 1984 .

[73]  R. Faull,et al.  Excitatory amino acid receptors in the human cerebral cortex: A quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine,l-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites , 1989, Neuroscience.

[74]  Michael V. Johnston,et al.  Physiological and pathophysiological roles of excitatory amino acids during central nervous system development , 1990, Brain Research Reviews.

[75]  J. Penney,et al.  Properties of Quisqualate‐Sensitive L‐[3H]Glutamate Binding Sites in Rat Brain as Determined by Quantitative Autoradiography , 1988, Journal of neurochemistry.

[76]  Distribution of [3H]MK801 binding in the normal aged human hippocampus , 1989, Brain Research.